Regen BioPharma, Inc. (OTCMKTS:RGBP) Short Interest Update

Regen BioPharma, Inc. (OTCMKTS:RGBP) was the target of a large growth in short interest during the month of June. As of June 15th, there was short interest totaling 1,854,604 shares, a growth of 445.6% from the May 31st total of 339,948 shares. Based on an average daily volume of 64,500,748 shares, the short-interest ratio is currently 0.0 days.

Regen BioPharma Stock Performance

Regen BioPharma has a 52-week low of $0.00 and a 52-week high of $0.12.

Regen BioPharma Company Profile

Regen BioPharma, Inc is a development‐stage biotechnology company focused on advancing regenerative medicine and immunotherapy products through stem cell science. The company’s research efforts center on identifying and developing novel therapeutic candidates that harness the regenerative potential of adult and embryonic stem cells, with an emphasis on cancer, infectious and autoimmune diseases.

Its primary activities include the discovery and preclinical validation of stem cell‐derived receptors and peptides, the development of immuno‐oncology assets, and the filing of investigational new drug (IND) applications to support first‐in‐human studies.